LT2474309T - Farmacinė kompozicija, apimanti ibuprofeną, tramadolį ir bazinę aminorūgštį, jos gavimo būdas ir naudojimas - Google Patents

Farmacinė kompozicija, apimanti ibuprofeną, tramadolį ir bazinę aminorūgštį, jos gavimo būdas ir naudojimas

Info

Publication number
LT2474309T
LT2474309T LTEP10813374.5T LT10813374T LT2474309T LT 2474309 T LT2474309 T LT 2474309T LT 10813374 T LT10813374 T LT 10813374T LT 2474309 T LT2474309 T LT 2474309T
Authority
LT
Lithuania
Prior art keywords
tramadol
ibuprofen
preparation
amino acid
pharmaceutical composition
Prior art date
Application number
LTEP10813374.5T
Other languages
English (en)
Inventor
Ana JIMÉNEZ REDONDO
Nuria SANZ MENÉNDEZ
Antonia Gomez Calvo
Fernando Martinez-Alzamora
Angel MUÑOZ RUIZ
Gonzalo Hernandez Herrero
Original Assignee
Farmalider, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider, S.A. filed Critical Farmalider, S.A.
Publication of LT2474309T publication Critical patent/LT2474309T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
LTEP10813374.5T 2009-09-04 2010-03-22 Farmacinė kompozicija, apimanti ibuprofeną, tramadolį ir bazinę aminorūgštį, jos gavimo būdas ir naudojimas LT2474309T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200901823A ES2356762B1 (es) 2009-09-04 2009-09-04 Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.
PCT/ES2010/000114 WO2011027009A1 (es) 2009-09-04 2010-03-22 Composición farmacéutica de ibuprofeno, tramadol y un aminoácido básico, procedimiento para su preparación y utilización de la misma

Publications (1)

Publication Number Publication Date
LT2474309T true LT2474309T (lt) 2018-12-10

Family

ID=43648916

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP10813374.5T LT2474309T (lt) 2009-09-04 2010-03-22 Farmacinė kompozicija, apimanti ibuprofeną, tramadolį ir bazinę aminorūgštį, jos gavimo būdas ir naudojimas

Country Status (10)

Country Link
EP (1) EP2474309B1 (lt)
CY (1) CY1120852T1 (lt)
DK (1) DK2474309T3 (lt)
ES (2) ES2356762B1 (lt)
HR (1) HRP20181988T1 (lt)
LT (1) LT2474309T (lt)
PL (1) PL2474309T3 (lt)
PT (1) PT2474309T (lt)
SI (1) SI2474309T1 (lt)
WO (1) WO2011027009A1 (lt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104666287B (zh) * 2011-07-08 2020-06-16 广州威尔曼新药研发有限公司 2-(4-异丁苯基)丙酸的药物组合物
ES2423866B1 (es) * 2012-02-22 2014-06-10 Farmalider, S.A. Composición farmaceútica de ibuprofeno y tramadol para inyección
ITMI20130210A1 (it) * 2013-02-14 2014-08-15 Menarini Lab Composizioni farmaceutiche contenenti dexketoprofene e tramadolo
ITMI20131028A1 (it) * 2013-06-20 2014-12-21 Italfarmaco Spa Arginina e/o citrullina per uso nel trattamento e/o nella prevenzione dell'artrosi
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
CN103720647A (zh) * 2013-12-16 2014-04-16 扬子江药业集团广州海瑞药业有限公司 一种右旋布洛芬注射液组合物
HUE062529T2 (hu) * 2019-07-09 2023-11-28 Farmalider Sa Ibuprofén és tramadol kombinációja fájdalom csillapítására
WO2021105524A1 (es) * 2019-11-25 2021-06-03 Mmc International Health Holding, S.L. Composición farmacéutica de la sal de ibuprofeno con lisina en forma de solución oral

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
AU2003264311A1 (en) * 2002-08-28 2004-04-08 Jin Wang Oral formulations of ibuprofen and tramadol, methods and preparation thereof
EP1964552B1 (en) * 2007-03-02 2009-08-26 Flamek Corp OÜ Analgesic composition of topically applied nonsteoridal antiinflammatory drugs and opioids
WO2008115572A1 (en) * 2007-03-21 2008-09-25 Theraquest Biosciences, Inc. Methods and compositions of nsaids
WO2008150324A1 (en) * 2007-03-26 2008-12-11 Theraquest Biosciences, Inc. Subanalgesic doses of drug combinations

Also Published As

Publication number Publication date
ES2700251T3 (es) 2019-02-14
HRP20181988T1 (hr) 2019-01-25
CY1120852T1 (el) 2019-12-11
SI2474309T1 (sl) 2019-02-28
PT2474309T (pt) 2018-11-30
ES2356762B1 (es) 2011-11-24
WO2011027009A1 (es) 2011-03-10
PL2474309T3 (pl) 2019-02-28
EP2474309A4 (en) 2013-11-27
EP2474309B1 (en) 2018-08-29
EP2474309A1 (en) 2012-07-11
DK2474309T3 (en) 2018-12-17
ES2356762A1 (es) 2011-04-13

Similar Documents

Publication Publication Date Title
HRP20181988T1 (hr) Farmaceutski pripravak koji sadrži ibuprofen, tramadol i bazičnu aminokiselinu, postupak njegove priprave i njegova upotreba
EP2429987A4 (en) AMIDE COMPOUND, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
IL217239A0 (en) Salts of rasagiline and pharmaceutical preparations thereof
ZA201108942B (en) Preparation comprising insulin, nicotinamide and an amino acid
TWI561257B (en) Extended release oral acetaminophen/tramadol dosage form
SG11201400769PA (en) Quinolyl-containing Hydroxamic Acid Compound and Preparation Method Thereof, and Pharmaceutical Composition Containing This Compound and Use Thereof
IL188681A0 (en) Pharmaceutical compositions and methods utilizing a d-amino acid
HK1166258A1 (en) A method for the preparation of high temperature stable oxygen-carrier- containing pharmaceutical composition and the use thereof
IL211018A (en) Inhibitors, processes for making them, medicinal preparations containing them and their use
ZA201106665B (en) Products comprising n-phenylpropenoyl amino acid amides and uses thereof
EP2358658A4 (en) PREPARATION OF RASAGILIN AND ITS SALTS
EP2762011A4 (en) AMINO ACID-BASED SEASONING COMPOSITION COMPRISING L-GLUTAMIC ACID AND BASIC AMINO ACIDS
HK1169379A1 (en) Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof 3-
ZA201109262B (en) Process for the preparation of a spray powder comprising one or more glycine-n,n-diacetic acid derivatives and use of the spray powder for producing compression agglomerates
ZA201107232B (en) Process for the preparation of cinacalcet and salts thereof, and intermediates for use in the process
EP2504331A4 (en) COMPOUND, SOME NEW FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF PREPARATION AND USE
IL226336A0 (en) A preparation containing insulin, nicotinamide and amino acid
EP2415869A4 (en) MODIFIED OLIGO-NUCLEIC ACID MOLECULE, PROCESS FOR PREPARATION AND USES THEREOF
HK1123998A1 (en) Pharmaceutical preparation containing garcinia acid and use thereof
IL207852A0 (en) Pharmaceutical composition comprising racetam and carnitine and process for its preparation
HK1148728A1 (en) Two-aromatic amino terminated dianthracene compound, preparation method and application
IL215316A (en) Medications containing tat hiv-derived amino acid sequences and their use in cancer treatment
HK1209022A1 (en) Amino acid derivatives used as pharmaceutical substances
EP2452681A4 (en) SALTS OF 13A- (S-) DESOXYTYLPHORININE, METHOD FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF
HK1125096A1 (en) Arene linked polyamine macrocylicderivatives, preparation method and pharmaceutical use thereof